Provided by Tiger Fintech (Singapore) Pte. Ltd.

FISHER & PAYKEL HEALTHCARE C

33.800
-0.150-0.44%
Volume:504.16K
Turnover:17.05M
Market Cap:19.82B
PE:57.89
High:34.040
Open:33.850
Low:33.450
Close:33.950
52wk High:35.422
52wk Low:28.660
Shares:586.27M
Float Shares:584.04M
Volume Ratio:1.04
T/O Rate:0.09%
Dividend:0.39
Dividend Rate:1.15%
EPS(TTM):0.584
EPS(LYR):0.589
ROE:20.67%
ROA:13.18%
PB:11.47
PE(LYR):57.42

Loading ...

Company Profile

Company Name:
FISHER & PAYKEL HEALTHCARE C
Exchange:
ASX
Establishment Date:
1934
Employees:
7412
Office Location:
15 Maurice Paykel Place,East Tamaki,Auckland,New Zealand
Zip Code:
2013
Fax:
64 9 574 0158
Introduction:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems. It provides its products for use in respiratory care, acute care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and within the hospital. The company offers adult respiratory products, including AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, accessories, and interfaces; and homecare products that include masks, CPAP devices, data management products, humidifiers, and accessories. It has operations in North America, Europe, the Asia Pacific, and internationally. The company was founded in 1934 and is headquartered in Auckland, New Zealand.